HCID 11185237, 화합물 → HCID 11267240, 화합물
반응식
[C:1]([C:5]1[C:6]([O:12][S:13]([C:16]2[CH:21]=[CH:20][C:19]([CH3:22])=[CH:18][CH:17]=2)(=[O:15])=[O:14])=[N:7][NH:8][C:9]=1[CH2:10][OH:11])([CH3:4])([CH3:3])[CH3:2].OCC1NN=C(OCC2N(C)N=CN=2)C=1C1C=CC=CC=1>>[C:1]([C:5]1[C:6]([O:12][S:13]([C:16]2[CH:21]=[CH:20][C:19]([CH3:22])=[CH:18][CH:17]=2)(=[O:15])=[O:14])=[N:7][NH:8][C:9]=1[CH:10]=[O:11])([CH3:4])([CH3:3])[CH3:2]참가 물질
3
실험 절차
This compound was prepared by the procedure described in Example 1, step d) using the product from Example 21, step c) instead of 5-hydroxymethyl-3-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-4-phenylpyrazole. Data for the title compound: 1H NMR (400 MHz, DMSO) δ 1.33+1.39 (9H, s+s) (tautomers present), 2.44 (3H, m), 6.55 (0.6H, m) (proton due to presence of aldehyde hydrate), 7.49-7.53 (2H, m), 7.79-7.98 (2H, m), 10.03 (0.2H, s) (tautomers present), 13.68 (0.2H, s); MS (ES+) m/e 323 [MH]+.
후처리
- customThis compound was prepared by the procedure
출처 및 근거
- ORD 기록
- ord-46c7182eb7a84f9a93377925068488dc